Page 2 - புற்றுநோய் ஜெநெடிக்ஸ் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Pharmacogenomics Market Size to Reach USD 11 97 Billion in 2027 | Increasing Incidence of Adverse Drug Reactions, Rising Investment and Funding for R&D are Factors Driving Industry Demand, says Emergen Research
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Worldwide Next-Generation Sequencing Industry to 2025 - Key Drivers and Trends
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Hematologic Malignancies Testing Market Share, Size, & Trends Analysis Report, Region, and Segment Forecasts, 2020 – 2028
emergenMay 23, 2021 1
The global Hematologic Malignancies Testing Market is forecasted to be worth USD 5.45 Billion by 2027, according to a current analysis by Emergen Research. In March 2020, Sysmex Corporation received japan marketing clearance for BGI Genomics Coronavirus kit distribution. This initiative will strengthen its position in Japan. During the forecast timeline, the Next-generation sequencing segment will hold the largest market with a CAGR of 14.8%. In next-generation sequencing, the steadily developing cohort of technologies allowing the detection of gene variations present in Rna and DNA. In the case of hematologic malignancies, such differences provide diagnostic relevance.
That included a mix of private and public capital, according to the Golden Valley-based Medical Alley Association.
Cash continues to flow into Minnesota’s medical startups. On Monday, the Medical Alley Association reported that its member companies raised more than $347 million during 2021’s first quarter.
That figure includes $109 million in private capital and $238 million through public markets, the med-tech trade group said in a news release. Investments in the first quarter are paving the way for “another record-breaking year” for Medical Alley, the group said.
“While 2020 was characterized by large, later-stage raises, 2021 is starting out with a refilling of the early-stage pipeline,” Medical Alley officials said in the release. “A total of 43 companies raised funds, nearly doubling Q1 2020’s total of 22.”
Share this article
Share this article
ResearchAndMarkets.com s offering.
The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted).
Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populations; cancer screening and early detection; and recurrence monitoring for cancer patients.
Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable the detection of biomarkers that are present
vimarsana © 2020. All Rights Reserved.